IR
Superintel
Overview
Markets
Watchlist
More
Oncogenex Pharmaceuticals in
CUSIP: 68230A906 | 3 institutional holders
Watch
Quarters
Q2 2017
Q1 2017
Q3 2016
Q2 2016
Q1 2016
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile